Soleno Therapeutics (SLNO) Change in Cash: 2013-2019
Historic Change in Cash for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to $9.5 million.
- Soleno Therapeutics' Change in Cash fell 23.27% to $9.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$2.4 million, marking a year-over-year decrease of 139.67%. This contributed to the annual value of -$81.8 million for FY2024, which is 152.72% down from last year.
- According to the latest figures from Q4 2019, Soleno Therapeutics' Change in Cash is $9.5 million, which was up 322.25% from -$4.3 million recorded in Q3 2019.
- In the past 5 years, Soleno Therapeutics' Change in Cash ranged from a high of $12.4 million in Q4 2018 and a low of -$4.3 million during Q3 2019.
- Moreover, its 3-year median value for Change in Cash was -$2.1 million (2018), whereas its average is $1.5 million.
- Per our database at Business Quant, Soleno Therapeutics' Change in Cash tumbled by 550.23% in 2015 and then soared by 683.65% in 2017.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Change in Cash stood at $774,813 in 2015, then crashed by 446.99% to -$2.7 million in 2016, then skyrocketed by 526.00% to $11.5 million in 2017, then increased by 8.20% to $12.4 million in 2018, then decreased by 23.27% to $9.5 million in 2019.
- Its Change in Cash was $9.5 million in Q4 2019, compared to -$4.3 million in Q3 2019 and -$3.9 million in Q2 2019.